World Health Organization launches call for high-level experts to join the Science Council: Geneva Tuesday, December 16, 2025, 09:00 Hrs [IST] The World Health Organization (WHO) ...
IPC 2025 to ignite innovation, knowledge & industry synergy paving promising avenues for pharma business: Nandita Vijaysimha, Bengaluru Tuesday, December 16, 2025, 08:00 Hrs [IST] ...
Commerce ministry to facilitate industry connect with regulators on December 17 to boost pharma exports: Shardul Nautiyal, Mumbai Tuesday, December 16, 2025, 08:00 Hrs [IST] In or ...
India’s lifescience starts-ups see regulatory compliance as a key hurdle for growth: Nandita Vijayasimha, Bengaluru Tuesday, December 16, 2025, 08:00 Hrs [IST] Indian lifescienc ...
Panel recommends health ministry to set up industry advisory board: Gireesh Babu, New Delhi Tuesday, December 16, 2025, 08:00 Hrs [IST] The Parliamentary Panel on Health and Famil ...
US FDA approves Innoviva’s Nuzolvence, a first-in-class, single-dose, oral antibiotic to treat uncomplicated urogenital gonorrhoea in adults?and adolescents: Waltham, Massachuse ...
MOC Cancer Care Centre hosts ONCO 3Sixty 2025 bringing together multi-oncology community: Our Bureau, Mumbai Monday, December 15, 2025, 17:40 Hrs [IST] MOC Cancer Care & Research ...
Greenspace Herbs, the Bengaluru-based company has opened a full-scale US office in New Jersey. The expansion comes as international supplement brands rush to secure a supply of the company's ...
IHH Healthcare sets for next phase of growth in India with successful closure of the open offer for Fortis Healthcare and Fortis Malar Hospitals: Our Bureau, Bengaluru Monday, Dec ...
ICMR funds new clinical trial to test effective dosing strategy of high-cost cancer drug PARP inhibitor: Our Bureau, Mumbai Monday, December 15, 2025, 17:10 Hrs [IST] Funded by th ...
EMA recommends conditional marketing authorisation for Serum Life Science Europe’s Anktiva to treat non-muscle invasive bladder cancer: Amsterdam, The Netherland Monday, Decembe ...
Biocon Biologics inks settlement and license agreement to commercialize biosimilar aflibercept worldwide: Our Bureau, Bengaluru Monday, December 15, 2025, 16:45 Hrs [IST] Biocon B ...